Chemed Inc (CHE) 107.38 $CHE
Chemed reports February 17
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 12:10PM CST
CHE: 107.38 (-0.43)
How Useful Is the PEG Ratio?
Anders Bylund, The Motley Fool - Motley Fool - Fri Jan 23, 7:00PM CST
The PEG ratio is a useful shorthand for stock valuation. You get it by dividing a stock's current price-to-earnings ratio by its earnings growth rate. You want the number to be low, but not negative. Master investor Peter Lynch loves this tool....
WCC: 68.20 (+1.34), PL: 69.95 (-0.01), JACK: 87.12 (-1.00), ESL: 115.76 (+0.80), CHE: 107.38 (-0.43), DECK: 77.08 (+0.61), SBH: 33.10 (+0.28), CRI: 83.65 (+0.52), AMED: 28.62 (+0.16), BKE: 49.59 (-0.16)
Chemed to Report Fourth-Quarter 2014 Earnings February 17, Related Conference Call to Be Held on February 18
Business Wire - Fri Jan 23, 1:02PM CST
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2014, on Tuesday, February 17, 2015, following the close of trading on the New York Stock Exchange.
CHE: 107.38 (-0.43)
Chemed Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Jan 08, 11:41AM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at approximately 8:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
CHE: 107.38 (-0.43), JPM: 59.67 (+0.10)
AmSurg Banks on Sheridan Buy to Boost Ambulatory Services - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 1:30PM CST
On Dec 28, we issued an updated research report on AmSurg Corporation (AMSG).
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), ADUS: 21.57 (+0.18), AMED: 28.62 (+0.16)
United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), LHCG: 30.42 (-0.57), BIOS: 6.04 (-0.06), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
Business Wire - Wed Dec 03, 3:00PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m. (ET) at the Crowne Plaza Hotel in New York City.
CHE: 107.38 (-0.43)
Comparing America's 3 Largest Home Health Care Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 21, 6:50AM CST
CHE: 107.38 (-0.43), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
26.25% Annual Return With Lobbying Stocks? Here Is How It Works...
Dividend Yield - at Seeking Alpha - Fri Nov 21, 4:32AM CST
I found an interesting portfolio investing idea: Invest in stocks that spend a huge amount of money to support political campaigns. It's no wonder that corporations have a huge interest in spending money for politics: Each dollar should create a...
FDX: 176.47 (+0.17), CHE: 107.38 (-0.43), KND: 19.68 (-0.38), LMT: 196.95 (-0.53), ITC: 38.75 (-0.53), TXT: 44.68 (+0.49), HLS: 45.01 (+0.30), SO: 45.88 (-0.68)
Will DaVita Kidney Care Gain On Medtronic Collaboration? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:00AM CST
DaVita HealthCare Partners Inc.'s (DVA) division DaVita Kidney Care, a leading provider of kidney care services, announced a joint venture with Medtronic.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16)
Insider Trading Alert - FIS, RP And CHE Traded By Insiders
at The Street - Tue Nov 18, 9:30AM CST
Stocks with insider trader activity include FIS, RP and CHE
CHE: 107.38 (-0.43), FIS: 66.52 (+0.33), RP: 19.30 (+0.49)
Post Earnings Update: Chemed Has Climbed 0.7% Higher in Past 2 Weeks (CHE)
Comtex SmarTrend(R) - Mon Nov 17, 8:57AM CST
18 days ago, on October 30th, 2014, Chemed (NYSE:CHE) reported its earnings. Analysts, on average, expected earnings of $1.51 per share on sales of $360.0 million. Chemed actually reported earnings of $1.48 per share on sales of $358.4 million, missing EPS estimates by $0.03 and missing revenue estimates by $1.6 million. Since the company's report, shares of Chemed have risen from $106.09 to $106.87, representing a gain of 0.7% in the past 18 days.
CHE: 107.38 (-0.43)
OJSC Cherkizovo Group: 9 Months 2014 Financial Results Announcement
Marketwired - Wed Nov 12, 5:09AM CST
OJSC Cherkizovo Group (LSE: CHE)
CHE: 107.38 (-0.43)
Chemed's board reports 174th consecutive quarterly dividend of USD0.22 per share
M2 - Mon Nov 10, 8:17AM CST
The board of directors of Chemed (NYSE:CHE), a hospice care company, on Friday declared a quarterly dividend of USD0.22 per share on the company's capital stock.
CHE: 107.38 (-0.43)
Chemed Corporation declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 12:41PM CST
CHE: 107.38 (-0.43)
Chemed Corporation Declares Quarterly Dividend of 22 Cents
Business Wire - Fri Nov 07, 12:18PM CST
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 22 cents per share on the Company's capital stock, payable on December 8, 2014, to shareholders of record as of November 17, 2014. This represents the 174th consecutive quarterly dividend paid by Chemed in its 43 years as a public company.
CHE: 107.38 (-0.43)
Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), AMED: 28.62 (+0.16)
Chemed Corporation to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Tue Nov 04, 12:23PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2014 Credit Suisse Healthcare Conference on Tuesday, November 11, 2014, at approximately 11:30 a.m. (MT) at the Arizona Biltmore Hotel in Phoenix, AZ.
CHE: 107.38 (-0.43)
Chemed reports February 17
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 12:10PM CST
CHE: 107.38 (-0.43)
How Useful Is the PEG Ratio?
Anders Bylund, The Motley Fool - Motley Fool - Fri Jan 23, 7:00PM CST
The PEG ratio is a useful shorthand for stock valuation. You get it by dividing a stock's current price-to-earnings ratio by its earnings growth rate. You want the number to be low, but not negative. Master investor Peter Lynch loves this tool....
WCC: 68.20 (+1.34), PL: 69.95 (-0.01), JACK: 87.12 (-1.00), ESL: 115.76 (+0.80), CHE: 107.38 (-0.43), DECK: 77.08 (+0.61), SBH: 33.10 (+0.28), CRI: 83.65 (+0.52), AMED: 28.62 (+0.16), BKE: 49.59 (-0.16)
Chemed to Report Fourth-Quarter 2014 Earnings February 17, Related Conference Call to Be Held on February 18
Business Wire - Fri Jan 23, 1:02PM CST
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2014, on Tuesday, February 17, 2015, following the close of trading on the New York Stock Exchange.
CHE: 107.38 (-0.43)
Chemed Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Thu Jan 08, 11:41AM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 33rd Annual J.P. Morgan Healthcare Conference on Thursday, January 15, 2015, at approximately 8:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.
CHE: 107.38 (-0.43), JPM: 59.67 (+0.10)
AmSurg Banks on Sheridan Buy to Boost Ambulatory Services - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 1:30PM CST
On Dec 28, we issued an updated research report on AmSurg Corporation (AMSG).
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), ADUS: 21.57 (+0.18), AMED: 28.62 (+0.16)
United States Home Health and Hospice Care Industry Analytics 2014-2021 - Market to reach $141 Billion by 2021
M2 - Mon Dec 15, 8:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/8wh7p6/home_health_and) has announced the addition of Plunkett Research Ltd's new report "Home Health and Hospice Care Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 621600" to their offering. Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: - Home Health and Hospice Care Industry (U.S.) to reach $131.3 billion by 2021. - Home Health and Hospice Care Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1. Comprehensive overview of an industry's financial results, ratios, vital statistics and metrics in one package 2. Complete benchmarking of the industry and its top companies 3. Deep industry and company financials This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked In-Depth Profiles, Financial Reports, Ranks & Executive Lists for Top U.S.-Based Corporations Top Companies Ranked - Market Capitalization - Employees - Revenue - Net Income - 3-Year Revenue Growth - 3-Year Income Growth - Return on Assets - Return on Equity - Return on Invested Capital List of Leading (Public and Private) Companies - Addus Homecare Corp - Almost Family Inc - Amedisys Inc - American HomePatient Inc - Apria Healthcare Group Inc - BioScrip Inc - Chemed Corporation - Gentiva Health Services Inc - LHC Group Inc - Lincare Holdings Inc For more information visit http://www.researchandmarkets.com/research/8w...health_and Source: Plunkett Research Ltd
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), LHCG: 30.42 (-0.57), BIOS: 6.04 (-0.06), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Quest Diagnostics' Virus Test Kit Wins FDA Clearance Again - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Dec 12, 2:40PM CST
Studies conducted by Quest Diagnostics (DGX) over time have shown that the Simplexa test kit can offer fast, reliable results within an hour.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
The Right Time to Invest in Amedisys (AMED)? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 09, 4:15PM CST
On Dec 8, 2014, we issued an updated research report on Amedisys Inc. (AMED).
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
Chemed Corporation to Present at the Oppenheimer 25th Annual Healthcare Conference
Business Wire - Wed Dec 03, 3:00PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Oppenheimer 25th Annual Healthcare Conference on Wednesday, December 10, 2014, at approximately 8:00 a.m. (ET) at the Crowne Plaza Hotel in New York City.
CHE: 107.38 (-0.43)
Comparing America's 3 Largest Home Health Care Companies
Joseph Cafariello - at Seeking Alpha - Fri Nov 21, 6:50AM CST
CHE: 107.38 (-0.43), AMED: 28.62 (+0.16), GTIV: 19.19 (-0.23)
26.25% Annual Return With Lobbying Stocks? Here Is How It Works...
Dividend Yield - at Seeking Alpha - Fri Nov 21, 4:32AM CST
I found an interesting portfolio investing idea: Invest in stocks that spend a huge amount of money to support political campaigns. It's no wonder that corporations have a huge interest in spending money for politics: Each dollar should create a...
FDX: 176.47 (+0.17), CHE: 107.38 (-0.43), KND: 19.68 (-0.38), LMT: 196.95 (-0.53), ITC: 38.75 (-0.53), TXT: 44.68 (+0.49), HLS: 45.01 (+0.30), SO: 45.88 (-0.68)
Will DaVita Kidney Care Gain On Medtronic Collaboration? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 18, 11:00AM CST
DaVita HealthCare Partners Inc.'s (DVA) division DaVita Kidney Care, a leading provider of kidney care services, announced a joint venture with Medtronic.
CHE: 107.38 (-0.43), AFAM: 30.88 (+0.37), DVA: 73.10 (-3.29), AMED: 28.62 (+0.16)
Insider Trading Alert - FIS, RP And CHE Traded By Insiders
at The Street - Tue Nov 18, 9:30AM CST
Stocks with insider trader activity include FIS, RP and CHE
CHE: 107.38 (-0.43), FIS: 66.52 (+0.33), RP: 19.30 (+0.49)
Post Earnings Update: Chemed Has Climbed 0.7% Higher in Past 2 Weeks (CHE)
Comtex SmarTrend(R) - Mon Nov 17, 8:57AM CST
18 days ago, on October 30th, 2014, Chemed (NYSE:CHE) reported its earnings. Analysts, on average, expected earnings of $1.51 per share on sales of $360.0 million. Chemed actually reported earnings of $1.48 per share on sales of $358.4 million, missing EPS estimates by $0.03 and missing revenue estimates by $1.6 million. Since the company's report, shares of Chemed have risen from $106.09 to $106.87, representing a gain of 0.7% in the past 18 days.
CHE: 107.38 (-0.43)
OJSC Cherkizovo Group: 9 Months 2014 Financial Results Announcement
Marketwired - Wed Nov 12, 5:09AM CST
OJSC Cherkizovo Group (LSE: CHE)
CHE: 107.38 (-0.43)
Chemed's board reports 174th consecutive quarterly dividend of USD0.22 per share
M2 - Mon Nov 10, 8:17AM CST
The board of directors of Chemed (NYSE:CHE), a hospice care company, on Friday declared a quarterly dividend of USD0.22 per share on the company's capital stock.
CHE: 107.38 (-0.43)
Chemed Corporation declares $0.22 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 12:41PM CST
CHE: 107.38 (-0.43)
Chemed Corporation Declares Quarterly Dividend of 22 Cents
Business Wire - Fri Nov 07, 12:18PM CST
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 22 cents per share on the Company's capital stock, payable on December 8, 2014, to shareholders of record as of November 17, 2014. This represents the 174th consecutive quarterly dividend paid by Chemed in its 43 years as a public company.
CHE: 107.38 (-0.43)
Amsurg's Q3 Earnings Top on Revenue Growth, View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 11:20AM CST
Amsurg Corp. (AMSG) reported third-quarter 2014 adjusted earnings per share (EPS) of 66 cents from continuing operations.
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), AMED: 28.62 (+0.16)
Chemed Corporation to Present at the 2014 Credit Suisse Healthcare Conference
Business Wire - Tue Nov 04, 12:23PM CST
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 2014 Credit Suisse Healthcare Conference on Tuesday, November 11, 2014, at approximately 11:30 a.m. (MT) at the Arizona Biltmore Hotel in Phoenix, AZ.
CHE: 107.38 (-0.43)
